710 Participants Needed

Palliative Care for Parkinson's Disease

(COPE-PD Trial)

BK
CS
Overseen ByChristina Seger
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Rochester
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if training community doctors in palliative care and providing telemedicine support can improve the quality of life for individuals with Parkinson's disease or Lewy Body Dementia and their caregivers. Palliative care focuses on alleviating symptoms such as pain and depression while addressing emotional and spiritual needs. Participants will either receive the usual care from their neurologists or gain access to enhanced support through online services and trained doctors. This trial may suit those over 40 diagnosed with Parkinson's or similar conditions who are not already receiving palliative or hospice care. As an unphased trial, this study offers a unique opportunity to explore innovative care approaches that could significantly enhance participants' quality of life.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this palliative care training and telemedicine support are safe for patients with Parkinson's disease and related conditions?

Research has shown that training community neurologists in palliative care, combined with telehealth support, is generally safe and well-received. One study found that 95% of participants using telepalliative care services felt they received better care than with traditional methods. This indicates that the treatment is not only safe but also appreciated by users.

The treatment trains doctors to better support patients with Parkinson's disease and similar conditions through online methods, including support groups and educational resources. No significant reports of harm or negative effects have emerged from this approach.

Overall, the goal is to improve quality of life by addressing pain, depression, and other symptoms. This method uses technology to provide care without requiring in-person visits, which many find convenient and helpful.12345

Why are researchers excited about this trial?

Researchers are excited about the Online Community-Supported Palliative Care for Parkinson's disease because it offers a new approach to managing symptoms and improving quality of life. Unlike traditional treatments that focus primarily on medication management and physical therapy, this intervention emphasizes training neurologists in palliative care through teleconferences, enhancing their ability to provide comprehensive care. Additionally, it provides patients and their caregivers access to online support groups and tailored educational resources, fostering a more holistic and supportive care environment. This innovative method has the potential to significantly enhance patient and caregiver experiences by integrating community resources and expert support into everyday care.

What evidence suggests that this trial's palliative care interventions could be effective for Parkinson's disease and related conditions?

Research has shown that training community neurologists in palliative care, combined with telemedicine support, can improve the quality of life for patients with Parkinson's disease and similar conditions. In this trial, some participants will receive Online Community-Supported Palliative Care. Neurologists will learn about palliative care and consult with a remote team, offering patients and their families additional support services. This approach enhances life quality and aids in planning future care. Telehealth, which provides healthcare services remotely, facilitates timely support and personalized information for patients and caregivers. Overall, these findings suggest that online community-supported palliative care could effectively assist those living with Parkinson's disease.12367

Who Is on the Research Team?

BK

Benzi Kluger, MD

Principal Investigator

University of Rochester

Are You a Good Fit for This Trial?

This trial is for people over 40 with Parkinson's disease or related conditions like progressive supranuclear palsy, multiple system atrophy, and Lewy Body Dementia. It's not for those who can't commit to the study, need palliative care for other illnesses like advanced cancer, or are already receiving palliative or hospice care.

Inclusion Criteria

I am over 40 and diagnosed with Parkinson's or a similar condition.

Exclusion Criteria

I have a serious illness that needs comfort care, like metastatic cancer.
I am currently receiving care to ease symptoms or hospice services.
I am willing and able to follow the study's procedures.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Data Collection

Baseline data collection for usual care practices before intervention begins

12 months
Data collected every 3 months

Intervention

Community neurologists receive palliative care training and patients access online support services

12 months
Ongoing telemedicine support

Follow-up

Participants are monitored for quality of life and caregiver burden

6 months
Data collected every 3 months

What Are the Treatments Tested in This Trial?

Interventions

  • Online Community-Supported Palliative Care
Trial Overview The study tests how effective it is when community doctors get training in palliative care and patients along with their caregivers receive support through telemedicine. Palliative care aims to improve life quality by easing physical pain, depression, social issues, and spiritual needs using technology.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Group II: Online Community-Supported Palliative Care InterventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Rochester

Lead Sponsor

Trials
883
Recruited
555,000+

University of Colorado, Denver

Collaborator

Trials
1,842
Recruited
3,028,000+

Stanford University

Collaborator

Trials
2,527
Recruited
17,430,000+

Massachusetts General Hospital

Collaborator

Trials
3,066
Recruited
13,430,000+

Published Research Related to This Trial

Palliative care is crucial for patients with Parkinson's disease and related disorders, addressing not just physical symptoms but also psychological, social, and spiritual needs from the time of diagnosis.
Specialist palliative care enhances overall patient care by managing complex issues and improving the quality of life for both patients and their families, emphasizing collaboration among healthcare teams.
Specialist palliative care for Parkinson's disease.Oliver, D., Veronese, S.[2020]
This study will evaluate a nurse-led palliative care intervention for people with Parkinson's disease across seven European countries, focusing on Advance Care Planning (ACP) to improve patient quality of life and care coordination.
The primary goal is to measure the percentage of participants with documented ACP decisions after 6 months, while secondary outcomes will assess quality of life, symptom burden, and cost-effectiveness, providing insights into the feasibility and impact of palliative care in diverse settings.
Advance Care Planning and Care Coordination for People With Parkinson's Disease and Their Family Caregivers-Study Protocol for a Multicentre, Randomized Controlled Trial.Meinders, MJ., Gentile, G., Schrag, AE., et al.[2021]
Palliative care can significantly improve the quality of life for patients with Parkinson's disease (PD) not just in advanced stages, but also early in the disease course, highlighting the need for timely intervention.
Primary palliative care, delivered by neurologists or primary care providers, is well-suited to meet the palliative needs of most PD patients, but there is a need for better methods to identify these needs and enhance education for healthcare providers.
Palliative care and Parkinson's disease: outpatient needs and models of care over the disease trajectory.Tarolli, CG., Holloway, RG.[2020]

Citations

Patient and Family Outcomes of Community Neurologist ...This pragmatic trial evaluates whether palliative care training for neurologists and remote access to a palliative care team can improve ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/37955923/
Patient and Family Outcomes of Community Neurologist ...PC education for community neurologists and provision of team-based PC via telehealth is feasible and may improve QOL and advance care planning.
Community Outreach for Palliative Engagement ...The purpose of this study is to learn more about the effectiveness of palliative care training for community physicians and telemedicine support services ...
Patient and Family Outcomes of Community Neurologist ...This pragmatic trial evaluates whether palliative care training for neurologists and remote access to a palliative care team can improve outcomes in patients ...
Community Outreach for Palliative EngagementThe purpose of this study is to learn more about the effectiveness of palliative care training for community physicians and telemedicine ...
Patient and Family Outcomes of Community Neurologist ...95 percent of participants receiving telepalliative care services indicated that they received better care interventions compared to others.
Palliative Care for Parkinson's Disease (COPE-PD Trial)The purpose of this study is to learn more about the effectiveness of palliative care training for community physicians and telemedicine support services ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security